Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primaquine added to dihydroartemisinin-piperaquine to reduce malaria transmission in Vom
PACTR202607857642772Completed
- Sponsor
- Tsuung Ason Benjamin
- Start
- Mar 2015
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of primaquine, dihydroartemisinin and piperaquine in malaria (2 arms), sponsored by Tsuung Ason Benjamin. Primary endpoint: Overall risk of gametocyte carriage through day 28. Started Mar 2015; status: completed.
02
Drugs
primaquinedihydroartemisininpiperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202607857642772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607857642772.